InVivo Therapeutics Holdings EBITDA 2011-2023 | NVIVQ
InVivo Therapeutics Holdings ebitda from 2011 to 2023. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
|
InVivo Therapeutics Holdings Annual EBITDA (Millions of US $) |
|
|---|---|
| 2022 | $-11 |
| 2021 | $-10 |
| 2020 | $-9 |
| 2019 | $-11 |
| 2018 | $-13 |
| 2017 | $-24 |
| 2016 | $-24 |
| 2015 | $-22 |
| 2014 | $-17 |
| 2013 | $-18 |
| 2012 | $-12 |
| 2011 | $-9 |
| 2010 | $-3 |
|
InVivo Therapeutics Holdings Quarterly EBITDA (Millions of US $) |
|
|---|---|
| 2023-09-30 | $-3 |
| 2023-06-30 | $-2 |
| 2023-03-31 | $-2 |
| 2022-12-31 | $-2 |
| 2022-09-30 | $-3 |
| 2022-06-30 | $-3 |
| 2022-03-31 | $-3 |
| 2021-12-31 | $-3 |
| 2021-09-30 | $-2 |
| 2021-06-30 | $-2 |
| 2021-03-31 | $-2 |
| 2020-12-31 | $-2 |
| 2020-09-30 | $-2 |
| 2020-06-30 | $-2 |
| 2020-03-31 | $-2 |
| 2019-12-31 | $-3 |
| 2019-09-30 | $-3 |
| 2019-06-30 | $-3 |
| 2019-03-31 | $-3 |
| 2018-12-31 | $-3 |
| 2018-09-30 | $-2 |
| 2018-06-30 | $-3 |
| 2018-03-31 | $-5 |
| 2017-12-31 | $-5 |
| 2017-09-30 | $-6 |
| 2017-06-30 | $-7 |
| 2017-03-31 | $-7 |
| 2016-12-31 | $-7 |
| 2016-09-30 | $-6 |
| 2016-06-30 | $-6 |
| 2016-03-31 | $-5 |
| 2015-12-31 | $-5 |
| 2015-09-30 | $-6 |
| 2015-06-30 | $-6 |
| 2015-03-31 | $-5 |
| 2014-12-31 | $-4 |
| 2014-09-30 | $-4 |
| 2014-06-30 | $-5 |
| 2014-03-31 | $-5 |
| 2013-12-31 | $-5 |
| 2013-09-30 | $-5 |
| 2013-06-30 | $-5 |
| 2013-03-31 | $-3 |
| 2012-12-31 | $-5 |
| 2012-09-30 | $-3 |
| 2012-06-30 | $-3 |
| 2012-03-31 | $-2 |
| 2011-12-31 | $-2 |
| 2011-09-30 | $-2 |
| 2011-06-30 | $-2 |
| 2011-03-31 | $-1 |
| 2010-12-31 | $-1 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.000B | $0.000B |
| InVivo Therapeutics Holdings Corp. operates as a medical device company focused on utilizing polymers as a platform technology to develop treatments to improve function in individuals paralyzed as a result of traumatic spinal cord injury. The company intends to offer three products, including a biocompatible polymer scaffolding device to treat acute wound SCI; a biocompatible hydrogel for local controlled release of methylprednisolone to treat acute SCI; and a biocompatible polymer scaffolding device seeded with autologous hNSCs to treat acute and chronic SCI. InVivo Therapeutics Holdings Corp. is based in Cambridge, Massachusetts. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $216.559B | 24.96 |
| EssilorLuxottica (ESLOY) | France | $168.705B | 0.00 |
| Boston Scientific (BSX) | United States | $146.614B | 33.53 |
| Stryker (SYK) | United States | $136.781B | 27.16 |
| Medtronic (MDT) | Ireland | $115.955B | 16.35 |
| Lonza Group Ag (LZAGY) | Switzerland | $46.709B | 0.00 |
| Agilent Technologies (A) | United States | $41.609B | 26.93 |
| ResMed (RMD) | United States | $35.788B | 24.77 |
| GE HealthCare Technologies (GEHC) | United States | $34.442B | 16.47 |
| Koninklijke Philips (PHG) | Netherlands | $27.029B | 17.65 |
| Terumo (TRUMY) | Japan | $24.148B | 28.61 |
| Insulet (PODD) | United States | $22.134B | 74.16 |
| Zimmer Biomet Holdings (ZBH) | United States | $17.343B | 10.82 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $15.690B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $11.495B | 0.00 |
| Baxter (BAX) | United States | $9.227B | 7.45 |
| Bio-Rad Laboratories (BIO) | United States | $8.390B | 30.07 |
| Demant (WILYY) | Denmark | $7.359B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $3.891B | 10.52 |
| Envista Holdings (NVST) | United States | $3.313B | 19.01 |
| ICU Medical (ICUI) | United States | $3.144B | 21.41 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.120B | 0.00 |
| Prestige Consumer Healthcare (PBH) | United States | $2.944B | 13.06 |
| Haemonetics (HAE) | United States | $2.444B | 10.91 |
| Perrigo (PRGO) | Ireland | $2.078B | 5.21 |
| LeMaitre Vascular (LMAT) | United States | $1.953B | 41.88 |
| Curaleaf Holdings (CURLF) | Canada | $1.917B | 0.00 |
| QuidelOrtho (QDEL) | United States | $1.858B | 11.95 |
| Phibro Animal Health (PAHC) | United States | $1.668B | 16.66 |
| AtriCure (ATRC) | United States | $1.607B | 0.00 |
| Tilray Brands (TLRY) | Canada | $1.437B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.421B | 62.27 |
| AdaptHealth (AHCO) | United States | $1.399B | 20.27 |
| Kestra Medical Technologies (KMTS) | United States | $1.363B | 0.00 |
| Neogen (NEOG) | United States | $1.349B | 25.88 |
| BioLife Solutions (BLFS) | United States | $1.321B | 2757.00 |
| InMode (INMD) | Israel | $0.918B | 10.38 |
| Valneva SE (VALN) | France | $0.774B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.733B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.492B | 16.94 |
| SNDL (SNDL) | Canada | $0.486B | 0.00 |
| Omeros (OMER) | United States | $0.476B | 0.00 |
| Evolus (EOLS) | United States | $0.441B | 0.00 |
| CeriBell (CBLL) | United States | $0.437B | 0.00 |
| Surmodics (SRDX) | United States | $0.394B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.384B | 0.00 |
| Brainsway (BWAY) | Israel | $0.307B | 62.19 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.286B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.284B | 0.00 |
| Cerus (CERS) | United States | $0.278B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.273B | 0.00 |
| High Tide (HITI) | Canada | $0.263B | 0.00 |
| Owens & Minor (OMI) | United States | $0.259B | 2.60 |
| Aurora Cannabis (ACB) | Canada | $0.251B | 148.67 |
| Viemed Healthcare (VMD) | United States | $0.249B | 19.49 |
| Sanara MedTech (SMTI) | United States | $0.246B | 0.00 |
| Quanterix (QTRX) | United States | $0.240B | 0.00 |
| Exagen (XGN) | United States | $0.234B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.230B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.222B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.210B | 0.00 |
| Organigram Global (OGI) | Canada | $0.207B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.195B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.188B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.186B | 16.38 |
| FitLife Brands (FTLF) | United States | $0.184B | 22.66 |
| Biote (BTMD) | United States | $0.145B | 5.86 |
| Sharps Technology (STSS) | United States | $0.119B | 0.00 |
| Apyx Medical (APYX) | United States | $0.119B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.118B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.102B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.092B | 0.00 |
| Fonar (FONR) | United States | $0.092B | 11.99 |
| MacroGenics (MGNX) | United States | $0.091B | 0.00 |
| Agape ATP (ATPC) | $0.061B | 0.00 | |
| Nephros (NEPH) | United States | $0.060B | 47.42 |
| ImmuCell (ICCC) | United States | $0.057B | 33.16 |
| Cytosorbents (CTSO) | United States | $0.047B | 0.00 |
| Jin Medical (ZJYL) | China | $0.039B | 0.00 |
| Veru (VERU) | United States | $0.038B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.036B | 0.00 |
| Bonk (BNKK) | United States | $0.036B | 0.00 |
| Zynex (ZYXI) | United States | $0.034B | 0.00 |
| United-Guardian (UG) | United States | $0.032B | 12.50 |
| Modular Medical (MODD) | United States | $0.027B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.013B | 0.00 |
| INLIF (INLF) | China | $0.011B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.011B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.008B | 0.00 |
| Flora Growth (FLGC) | United States | $0.007B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.007B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.005B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.005B | 0.00 |
| Akanda (AKAN) | Canada | $0.001B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.000B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |